Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

9-2-2011

The challenges of assessing acute kidney injury in infants
Guido M. Filler
Schulich School of Medicine & Dentistry, guido.filler@lhsc.on.ca

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Filler, Guido M., "The challenges of assessing acute kidney injury in infants" (2011). Paediatrics
Publications. 1279.
https://ir.lib.uwo.ca/paedpub/1279

co m m e nta r y

see original article on page 655

The challenges of assessing
acute kidney injury in infants
Guido M. Filler1,2
Definitions of pediatric acute kidney injury (AKI) use changes of serum
creatinine. There is a paucity of well-designed studies in infants because
of creatinine age-dependency. The emerging role of cystatin C as a
superior marker of renal dysfunction led to a carefully conducted study
on AKI in infants by Zappitelli et al. This Commentary calls for the
development of age-independent serum creatinine and estimated
glomerular filtration rate z scores.
Kidney International (2011) 80, 567–568. doi:10.1038/ki.2011.172

Acute kidney injury (AKI) is a serious
condition that negatively affects the outcome of other conditions, particularly in
neonates and infants. Infants with AKI
have decreased survival compared with
those without AKI.1 There has been considerable debate about how best to define
AKI, with over 30 different definitions.2
To simplify this, a classification system
called RIFLE—based on the criteria of
risk, injury, failure, loss, and end-stage
renal disease — has been proposed to
standardize the definition of AKI in
adults, and the criteria correlate with
hospital mortality and adverse patient
outcomes.2 These criteria are based on
serum creatinine (SCr), as a surrogate
marker of glomerular filtration rate
(GFR), and urine output. In children,
variability of muscle mass, age, sex, diet,
amount of creatinine filtered by the
glomerulus, proximal tubule secretion,
tubular reabsorption, and gastrointestinal elimination renders SCr problematic
1Department of Pediatrics, Schulich School of
Medicine and Dentistry, London, Ontario, Canada
and 2Department of Pathology and Laboratory
Medicine, Schulich School of Medicine and
Dentistry, University of Western Ontario, London,
Ontario, Canada
Correspondence: Guido M. Filler, Department
of Pediatrics, Children’s Hospital, London Health
Science Centre, University of Western Ontario,
800 Commissioners Road East, London, Ontario,
Canada N6A 5W9. E-mail: guido.filler@lhsc.on.ca

Kidney International (2011) 80

as a tool for GFR assessment.3 Therefore,
a modified pediatric definition was necessary, and the pRIFLE criteria were
developed.4 However, very few infants
and no neonates were included in that
study. In neonates, SCr reflects largely the
maternal creatinine.5 During gestation,
GFR remains constant and SCr increases
with the baby’s length, but 24 hours after
delivery, SCr drops progressively, and
GFR increases threefold, then continues
to increase slowly thereafter and reaches
steady state at 18 months.6 Thereafter, the
absolute GFR increases with body length,
and therefore GFR is normalized to body
surface area, which makes it age-independent, while SCr continues to
increase.7 Even with normalization to
body surface area, GFR increases from
about 10 ml/min/1.73 m2 in infants to
90–150 ml/min/1.73 m2 in 2-year-old
children. Figure 1 demonstrates these
relationships between age and SCr,
based on the new reference intervals
by Boer et al.,8 and between age and the
new Schwartz estimated GFR, 9 based
on the reference intervals of Boer et al.
and standardized heights from the
US Centers for Disease Control and
Prevention (CDC) growth charts using
the 2000 Third National Health and
Nutrition Examination Survey (NHANES
III) data.10
These developmental changes in
SCr pose significant difficulties for the

development of an AKI definition that is
completely independent of age and sex. In
view of these difficulties, a growing
number of potential AKI biomarkers have
been studied, such as neutrophil gelatinase-associated lipocalin, kidney injury
molecule 1, liver fatty acid-binding protein, and cystatin C. It is timely to see a
new report on a large cohort of 288 infants
undergoing cardiac surgery in a multicenter study by Zappitelli et al.11 (this
issue). The authors studied cystatin C, a
novel marker of renal function that is
superior to creatinine,7 in comparison
with creatinine. They defined AKI as an
abrupt (within 48 hours) reduction in kidney function, currently defined as an
absolute increase in SCr of at least 0.3 mg/dl
(.26.4 mol/l), a percentage increase in
SCr of at least 50% (1.5-fold from baseline), or a reduction in urine output (documented oliguria of less than 0.5 ml/kg
per hour for more than 6 hours). They
used a creatinine-based and urine outputbased AKI definition and demonstrated
nicely that cystatin C independently predicted morbidity and length of stay. But is
their AKI definition, which is admittedly
the result of a large consensus effort, really
a good definition in view of the relatively
dramatic evolution of renal function
after birth?
Including an increase of SCr would
account for the age-dependency of SCr,
but an increase of 26.4 mol/l would overestimate the degree of AKI in newborns
compared with 1-year-olds. Normal
median SCr falls from 55 mol/l on day 1
to 21 mol/l at 1 year,8 which means that
the same cutoff would be half as important for the 1-year-old. Zappitelli et al.11
acknowledge these difficulties by excluding infants less than 1 month of age.
Indeed, it is most questionable what it
would mean if an SCr increases by
26.4 mol/l on day 2, when SCr is still
mostly the maternal creatinine. 5 An
increase of 50% is equally problematic in
view of the not-normally-distributed SCr
concentrations across all ages (Figure 1).
The problem is reduced by limitation of
study participants to greater than 1 month
and less than 2 years. However, congenital
heart disease may require open-heart surgery much earlier than at 1 month of age,
and clearly these patients are at risk for
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Figure 1 | Normal creatinine values by age. Taken from a recent publication on serum
creatinine reference intervals8 and the modified new Schwartz estimated GFR (eGFR),9
based on standardized heights from the US Centers for Disease Control and Prevention
growth charts using the 2000 Third National Health and Nutrition Examination Survey
(NHANES III) data (file no. 2, LENAGEINF, in ref. 10).

postoperative AKI. We need a definition
that is suitable across all ages.
To further address this issue, Zappitelli
et al.11 also used nuclear-medicine GFR
values from a previous study on 651 people to generate percentile curves. They
then plotted the study subjects into these
curves. Although this is certainly an
improvement over the definition used
above, a separate validation of the new
Schwartz formula9 in a large cohort of
infants against gold-standard GFR measurement remains elusive. Nonetheless,
this approach offers significant advantages
over an approach based merely on creatinine increase and percentage increase.
In pediatric practice, we are faced with
age-dependency of reference intervals all
the time, and we use charts to determine
percentiles. A better way still are age-independent z scores. Given a large enough
sample size (usually > 5000 to account for
both sexes and to cover all ages), methodologies such as Box–Cox transformations
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ent z scores, and to change the definitions
accordingly.
In conclusion, the study by Zappitelli
et al.11 definitely adds to the medical
literature and establishes the prognostic
value of cystatin C as an AKI marker in
infants at risk for AKI. The study also
demonstrates the limitations of the current pediatric AKI definitions and raises
the question of whether age-dependent
parameters of renal function need to be
expressed in a different form, perhaps as
age-independent z scores?

can be used to develop L, M, and S variables for each age (in months) to calculate
age-independent z scores. The CDC website10 offers a wealth of such approaches
for height, weight, body mass index ( > 2
years of age), weight for height, blood pressure, and so on. It is surprising that the
pediatric nephrology community has not
embraced this mathematical approach and
uses an AKI definition based on changes
of the z scores for either SCr, cystatin C, or
any estimated GFR. Expressing GFR and
SCr as age-independent z score will also
allow for better recognition of impaired
kidney function, because a newborn’s SCr
or cystatin C cannot be properly interpreted without consultation of appropriate
normative charts. The laboratories are not
assisting pediatricians and pediatric nephrologists by providing age-dependent reference intervals for every day of life.
Perhaps it is time that we use modern
information-technology support to report
all laboratory parameters as age-independ-
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